Yujiro Ueda

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “192P A multicenter crossover analysis of first and second-line FOLFIRINOX or gemcitabine plus nab-paclitaxel administered to pancreatic cancer patients: Results from the NAPOLEON study”.

192P A multicenter crossover analysis of first and second-line FOLFIRINOX or gemcitabine plus nab-paclitaxel administered to pancreatic cancer patients: Results from the NAPOLEON study

Annals of Oncology(2020)10.1016/j.annonc.2020.10.456

N/A

0DataRank · unranked

1 citations

Haruo Iguchi, Mototsugu Shimokawa, Tsuyoshi Shirakawa, F. Koga, Yujiro Ueda +14 more

473P A phase I study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in patients with advanced solid tumors including colorectal cancer (CRC)

Annals of Oncology(2021)10.1016/j.annonc.2021.08.994

N/A

0DataRank · unranked

1 citations

Satoru Iwasa, Kohei Shitara, Takafumi Koyama, Yujiro Ueda, Satoshi Nagao +7 more